Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Library

OM1

OM1 Website, Blog & Press Pages - aVenture Research

Library

om1.comCrawled Oct 31, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

Our Platform/our-platform
OM1's AI Outcomes Platform unites real-world data from 350M+ patients with agentic AI & PhenOM model to unlock actionable healthcare insights.
Our solutions/our-solutions
Explore OM1 solutions for real-world evidence, patient identification, and outcomes research powered by AI and longitudinal data.
Providers/who-we-help/providers
OM1 empowers providers with PhenOM AI: stratify patients for value-based care, predict outcomes, automate registries, and unlock research revenue.
Registry Center of Excellence/registry-center-of-excellence
OM1's Registry Center of Excellence delivers expert design, operations & analysis for registries and studies. FDA/EMA-aligned with proven global leadership.

Blog

6 pages

Avoiding Losses Under CMS TEAM and CJR-X: Managing Risk at the Point of Care/webinar-avoiding-losses-under-cms-team-and-cjr-x
The session discusses how episode losses in joint replacements are identified at the bedside and how predictive medicine helps surgeons and care managers address patient-level risk before reconciliation reports.
Hiding in Plain Sight: Leveraging AI to Redefine Patient Finding and Outcomes Prediction/ebook-hiding-in-plain-sight-volume-1
Description for 2Y3u1jtsd0w8LYFvMt1RWo
Registries Webinar Episode 1: Building Non-Interventional Studies for Regulatory Purposes/registries-webinar-series-episode-1
The page explains how to design registries, observational studies, and external control arms that comply with regulatory standards.
Resources/resources

Press

5 pages

OM1 at ISPE Annual 2026/ispe-annual-2026
OM1 presents research at the 42nd ISPE Annual Meeting, focusing on how its solutions apply pharmacoepidemiology to improve patient outcomes.
OM1 at ISPOR EU 2026/om1-at-ispor-eu-2026
OM1 exhibits and presents research at ISPOR EU in Vienna, highlighting how its solutions influence access through science and policy.
OM1 Frost and Sullivan Award.pdf/download/7wyFabbrc4agEw84E8t5um/om1_frost_and_sullivan_award.pdf
OM1 Publishes Validation Results from a Single Healthcare Foundation Model Across More than 1700 Predicted Clinical Outcomes/resources/press-release/other/om1-publishes-validation-results-from-a-single-healthcare-foundation-model-across-more-than-1700-predicted-clinical-outcomes
OM1, Inc. today announced the publishing of "Performance of a Foundation Model to Generate Thousands of Predicted Outcomes Across Multiple Use Cases."

Careers & Hiring

1 page

Careers/careers
Join OM1 and help transform healthcare with AI-driven real-world data, evidence generation, and patient-centered outcomes.

Team

6 pages

Ashish Deshpande/team/ashish-deshpande
Physician, Vice President & Head of Clinical Informatics
Eric Mertz/team/eric-mertz
Vice President and General Manager
Hunter Lane/team/hunter-lane
Chief Product Officer
Nick test page/nick-page-variant
Test page

About

1 page

About Us/about-us
OM1 pioneers AI-powered real-world data to measure outcomes, accelerate research & improve clinical decisions. 10+ patents since 2017. Boston-based.

Contact

1 page

Contact Us/contact-us
Contact OM1, Inc.: 230 Third Ave, 3rd floor, Waltham, MA, 02451, United States. Call +1 (888) 324-3899, email info@om1.com, send a message or book a demo.

Homepage

1 page

Homepage/
OM1 uses AI and real-world data to help life sciences and providers predict outcomes, accelerate research, and improve patient care.

Privacy

1 page

Privacy/privacy
OM1’s privacy policy describes data collection, usage, and protection practices, complying with GDPR, CCPA, and HIPAA, and outlines cookie management and user rights.

Terms & Conditions

1 page

Terms and conditions/terms-and-conditions